China SXT Pharmaceuticals Inc. - ADR

Name: China SXT Pharmaceuticals Inc. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: China SXT Pharmaceuticals Inc. - ADR

Stock Card

$2.26

$0.06 (2.82%)

As on 04-Sep-2026 13:23EDT

Market cap

$2 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

P/B Ratio

0.1

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

China SXT Pharmaceuticals - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.20 High: 2.36

52 Week Range

Low: 2.06 High: 83,758.80

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-- Mln
ROE

-0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

7.1
Debt to Equity

0
Book Value

$50.7
EPS

$-10.6
Face value

--
Shares outstanding

533,976

8 Years Aggregate

CFO

$2.44 Mln

EBITDA

$-2.05 Mln

Net Profit

$-20.65 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
China SXT Pharmaceuticals - ADR	-100.0	-63.2	-98.4	-100.0	-96.0	-90.8	--
BSE Sensex	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2021	2020
China SXT Pharmaceuticals - ADR	214.9	-70.7	-50.6	-59.9
S&P Small-Cap 600	4.0	13.9	25.3	9.6
BSE Sensex	9.1	18.7	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About China SXT Pharmaceuticals - ADR

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP,... and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China. Read more

Chairman of the Board & CEO

Mr. Feng Zhou
Chairman of the Board & CEO

Mr. Feng Zhou
Headquarters

Taizhou
Website

https://www.sxtchina.com

FAQs for China SXT Pharmaceuticals - ADR

What is the current share price of China SXT Pharmaceuticals Inc - ADR Today?

The share price of China SXT Pharmaceuticals Inc - ADR is $2.26 (NASDAQ) as of 04-Sep-2026 13:23 EDT. China SXT Pharmaceuticals Inc - ADR has given a return of -96% in the last 3 years.

What is the current PB & PE ratio of China SXT Pharmaceuticals Inc - ADR?

Since, TTM earnings of China SXT Pharmaceuticals Inc - ADR is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2026	-0.16	0.03
2025	-1.84	0.39
2024	-0.47	0.10
2023	-0.02	0.01
2022	0.00	0.00

What is the 52 Week High and Low of China SXT Pharmaceuticals Inc - ADR?

The 52-week high and low of China SXT Pharmaceuticals Inc - ADR are Rs 83,758.80 and Rs 2.06 as of 05-Sep-2026.

What is the market cap of China SXT Pharmaceuticals Inc - ADR?

China SXT Pharmaceuticals Inc - ADR has a market capitalisation of $ 2 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in China SXT Pharmaceuticals Inc - ADR?

Before investing in China SXT Pharmaceuticals Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.